Literature DB >> 22748005

The case-cohort design in outbreak investigations.

O Le Polain de Waroux1, H Maguire, A Moren.   

Abstract

The use of the case-cohort design for outbreak investigations has been limited. Here we discuss its strengths and limitations based on real and fictitious examples. The case-cohort is a case–control study where controls are sampled from the initial population at risk, and may thus include both cases and non-cases. An advantage of the design, compared to traditional case-control studies, is that risk ratios can easily be obtained directly from the cross-product of exposed and unexposed cases and controls (rare disease assumption is not required). We illustrate this in the context of point source gastrointestinal outbreaks and in field studies on vaccine effectiveness. The design is also useful to investigate multiple outcomes with a unique sample of controls or to test hypotheses when different case-definitions (from the most sensitive to the most specific) are used for a particular outcome. Strengths and limitations are presented, and discussed in the context of outbreak investigations.

Mesh:

Substances:

Year:  2012        PMID: 22748005

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  7 in total

1.  Risk Score to Predict Dental Caries in Adult Patients for Use in the Clinical Setting.

Authors:  Miguel de Araújo Nobre; Ana Sezinando; Inês Fernandes; Paulo Maló
Journal:  J Clin Med       Date:  2019-02-07       Impact factor: 4.241

2.  Adult Patient Risk Stratification Using a Risk Score for Periodontitis.

Authors:  Miguel de Araújo Nobre; Ana Ferro; Paulo Maló
Journal:  J Clin Med       Date:  2019-03-05       Impact factor: 4.241

3.  Methods for generating hypotheses in human enteric illness outbreak investigations: a scoping review of the evidence.

Authors:  C Ickert; J Cheng; D Reimer; J Greig; A Hexemer; T Kershaw; L Waddell; M Mascarenhas
Journal:  Epidemiol Infect       Date:  2019-09-27       Impact factor: 2.451

Review 4.  Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.

Authors:  C King; J Beard; A C Crampin; A Costello; C Mwansambo; N A Cunliffe; R S Heyderman; N French; N Bar-Zeev
Journal:  Vaccine       Date:  2015-07-30       Impact factor: 3.641

5.  Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study.

Authors:  Licia Iacoviello; Claudia Agnoli; Amalia De Curtis; Augusto di Castelnuovo; Maria Concetta Giurdanella; Vittorio Krogh; Amalia Mattiello; Giuseppe Matullo; Carlotta Sacerdote; Rosario Tumino; Paolo Vineis; Giovanni de Gaetano; Salvatore Panico; Maria Benedetta Donati
Journal:  BMJ Open       Date:  2013-11-14       Impact factor: 2.692

6.  Geodesic Monte Carlo on Embedded Manifolds.

Authors:  Simon Byrne; Mark Girolami
Journal:  Scand Stat Theory Appl       Date:  2013-09-13       Impact factor: 1.396

7.  Effect of a rehabilitation-based chronic disease management program targeting severe COPD exacerbations on readmission patterns.

Authors:  C Lalmolda; R Coll-Fernández; N Martínez; M Baré; M Teixidó Colet; F Epelde; E Monsó
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.